Navigation Links
Researchers focus on helping dying patients take care of unfinished business
Date:11/17/2009

CLEVELAND--Hospice workers have watched patients emerge from comas and cling to life long enough to tell someone they love or forgive them.

This phenomenon of taking care of unfinished business has been observed, but researchers from the Frances Payne Bolton School of Nursing and the College of Arts and Sciences at Case Western Reserve University will begin groundbreaking studies to understand what drives the dying to live long enough to resolve these issues.

With the research data, they will design interventions to help patients in hospice care and families before and after the person passes.

Before now, end of life research primarily focused on making the patient comfortable by easing suffering or discomfort from the illness.

But, the approach of Barbara Daly and Mary Jo Prince-Paul from the School of Nursing and Julie Exline from Arts and Sciences is to relieve psychological distress by marshaling the patient's inner strengths and social connections.

These qualities include the resilient feelings of hope, optimism and connectedness that they mustered to make it through difficult and even life-threatening situations before their terminal illnesses. Marshaling these inner resources has been shown to improve the psychological outlook of healthy people, and the researchers want to find out the benefits for those severely ill.

In the past, researchers have shied away from approaching dying patients with questions, but among the goals of these projects is to give hospice patients options to participate in research. They also will organize a biomedical research group interested in palliative care that focuses on the patients' and family members' inner strength.

Daly, the Gertrude Perkins Oliva Professor of Oncology Nursing at Case Western Reserve and clinical ethics director at University Hospitals Case Medical Center, will establish the BEST Center (Building End-of-Life Science through Positive H
'/>"/>

Contact: Susan Griffith
susan.griffith@case.edu
216-368-1004
Case Western Reserve University
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Mount Sinai researchers to test first gene therapy For Alzheimers patients
2. Wistar researchers show targeting normal cells in tumors slows growth
3. K-State researchers studying link between climate change and cattle nutritional stress
4. Cornell Researchers Identify a Weak Link in Cancer Cell Armor
5. Researchers notch a victory toward new kind of cancer drug
6. Emotions increase or decrease pain: researchers
7. Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits
8. U-M Researchers Receive $1.8 Million Grant to Develop New Therapy for Neuropathic Pain
9. Researchers show how to divide and conquer social network of cells
10. Connection between depression and osteoporosis detailed by Hebrew University researchers
11. Researchers find new way to attack inflammation in Graves eye disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... London, UK (PRWEB) July 11, 2014 ... segment of the in-vitro diagnostics industry, which is expected ... next ten years. The sector owes its growth to ... threat to people’s health worldwide and a major factor ... diagnostic technologies, threat of bio-terrorism, and a broader availability ...
(Date:7/11/2014)... Utilizing the Keller Funnel, Quatela Center for ... a record number of complication-free breast augmentations. Far ... procedures without the occurrence of a capsular contraction. ... country for his expertise with the breast augmentation procedure. ... foundation for numerous studies and research. Most recently, ...
(Date:7/11/2014)... July 11, 2014 Ticket Down is ... Concord Pavilion . When it comes to the summer concert ... The 37-year-old Georgia native is one of the biggest names in ... business. Bryan is currently out on his “That’s My Kind of ... stops the tour will be making through the rest of the ...
(Date:7/11/2014)... July 11, 2014 Biostimulants are widely ... in turf and ornamentals. These also help turf and ... length of roots. Turf, ornamentals, and flowers appear healthy ... this usage has increased from the last few years. ... and ornamentals is Europe, with around 40% share in ...
(Date:7/11/2014)... kind has found that organic foods and crops ... counterparts, including more antioxidants and fewer, less frequent ... unprecedented 343 peer-reviewed publications comparing the nutritional quality ... including fruits, vegetables, and grains. The study team ... organic and non-organic foods. , "Science marches ...
Breaking Medicine News(10 mins):Health News:World Virology and Bacteriology Testing Sector Discussed in Comprehensive VPG Research Report Published at MarketPublishers.com 2Health News:World Virology and Bacteriology Testing Sector Discussed in Comprehensive VPG Research Report Published at MarketPublishers.com 3Health News:Rochester Surgeon Hits Milestone with Keller Funnel 2Health News:Luke Bryan Ticket Prices Slashed at Concord Pavilion 2Health News:Luke Bryan Ticket Prices Slashed at Concord Pavilion 3Health News:Biostimulants Market in Turf and Ornamentals is Expected to Reach $ 3.8 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:Biostimulants Market in Turf and Ornamentals is Expected to Reach $ 3.8 Billion by 2018 - New Report by MicroMarket Monitor 3Health News:Major study documents nutritional and food safety benefits of organic farming 2Health News:Major study documents nutritional and food safety benefits of organic farming 3
... Kathleen Doheny HealthDay Reporter , THURSDAY, Oct. 7 ... cancer who have dense breasts may be at higher risk ... breast, a new study indicates. "The risk appears to ... that originally had the cancer," said Laurel A. Habel, a ...
... (Oct. 7, 2010)In 2006, Dr. Shimya Yaminaka of Kyoto ... medicine research world on fire when he successfully transformed ... behave like embryonic stem cells. Embryonic stem cells, the ... the ability to differentiate into any type of tissue. ...
... which participants are randomly assigned to different treatments by ... correctly, it,s widely accepted by the research community that ... But researchers at the University of Michigan ... medical devices to patients by investigating the impact of ...
... HealthDay Reporter , WEDNESDAY, Oct. 6 (HealthDay News) ... be taken with the blood thinner Plavix, a new ... medications, called PPIs, might interfere with the ability of ... reassuring data that there is not any clinically significant ...
... perhaps more than anyone realizes -- in basic biological ... reducing cancer risks, according to University of Oregon researchers. ... zebrafish, scientists in the UO Institute of Molecular Biology ... in the sterile environment of its eggshell through the ...
... friends and family members of mood history and symptoms ... research published online by the journal International Psychogeriatrics ... who is highly outgoing and fun-loving and who is ... miss the signs that indicate the person is depressed. ...
Cached Medicine News:Health News:Denser Breasts Raise Odds of Second Breast Cancer, Study Finds 2Health News:Denser Breasts Raise Odds of Second Breast Cancer, Study Finds 3Health News:Colorado researcher discovers mechanism for changing adult cells into stem-like cells 2Health News:U-M receives NIH, FDA grant to study adaptive clinical trial designs 2Health News:Heartburn Drugs, Plavix Seem Safe to Take Together 2Health News:Heartburn Drugs, Plavix Seem Safe to Take Together 3Health News:Gut microbes promote cell turnover by a well-known pathway 2Health News:Patient personality hinders detection of depression 2
(Date:7/11/2014)... 11, 2014 Research and Markets  has ... Market 2014-2018" report to their offering. ... needle is a hollow needle commonly used with a ... to extract fluids from it. A hypodermic needle is ... substances that cannot be ingested. Hypodermic needles are broadly ...
(Date:7/11/2014)... MELBOURNE, Australia , July 11, 2014  Australian ... today announced that it has raised A$19.3 million via ... Europe , the U.S., ... and A$3 million from a share purchase plan (SPP) ... A$16.3 million will be made in two tranches. ...
(Date:7/11/2014)... New York , July 11, 2014 ... by Transparency Market Research "Endoscopy Devices Market (Endoscopes, Endoscopic ... Size, Share, Growth, Trends and Forecast, 2013-2019" the global ... in 2012 and is expected to grow at a ... an estimated value of USD 36.9 billion in 2019. ...
Breaking Medicine Technology:Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 2Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 3Phosphagenics' A$19.3 million Capital Raising 2Phosphagenics' A$19.3 million Capital Raising 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 5Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 6
... A. Grant, MD,Retina Macular Care, presented the ... that was designed to evaluate the adjuvant,use ... Lucentis(R),(ranibizumab) treatment of choroidal neovascularization secondary to,age-related ... presentation at,the 2008 Annual Meeting of the ...
... C Therapies Provides ... Clinical Practice, MILAN, Italy, April 26 Final ... study comparing the,leading therapies for chronic hepatitis C, were ... Association for the Study of the Liver,(EASL), providing important ...
Cached Medicine Technology:Dr. Calvin Grant Presents Results from Xibrom(TM) Combination Therapy with Lucentis(R) at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) 2Dr. Calvin Grant Presents Results from Xibrom(TM) Combination Therapy with Lucentis(R) at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) 3Dr. Calvin Grant Presents Results from Xibrom(TM) Combination Therapy with Lucentis(R) at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) 4Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 2Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 3Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 4Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 5Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 6Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 7Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 8Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 9Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 10